Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Environ Pollut ; 226: 452-462, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28431762

ABSTRACT

Chemical contamination of aquatic systems often co-occurs with dramatic changes in surrounding terrestrial vegetation. Plant leaf litter serves as a crucial resource input to many freshwater systems, and changes in litter species composition can alter the attributes of freshwater communities. However, little is known how variation in litter inputs interacts with chemical contaminants. We investigated the ecological effects resulting from changes in tree leaf litter inputs to freshwater communities, and how those changes might interact with the timing of insecticide contamination. Using the common insecticide malathion, we hypothesized that inputs of nutrient-rich and labile leaf litter (e.g., elm [Ulmus spp.] or maple [Acer spp.]) would reduce the negative effects of insecticides on wetland communities relative to inputs of recalcitrant litter (e.g., oak [Quercus spp.]). We exposed artificial wetland communities to a factorial combination of three litter species treatments (elm, maple, and oak) and four insecticide treatments (no insecticide, small weekly doses of 10 µg L-1, and either early or late large doses of 50 µg L-1). Communities consisted of microbes, algae, snails, amphipods, zooplankton, and two species of tadpoles. After two months, we found that maple and elm litter generally induced greater primary and secondary production. Insecticides induced a reduction in the abundance of amphipods and some zooplankton species, and increased phytoplankton. In addition, we found interactive effects of litter species and insecticide treatments on amphibian responses, although specific effects depended on application regime. Specifically, with the addition of insecticide, elm and maple litter induced a reduction in gray tree frog survival, oak and elm litter delayed tree frog metamorphosis, and oak and maple litter reduced green frog tadpole mass. Our results suggest that attention to local forest composition, as well as the timing of pesticide application might help ameliorate the harmful effects of pesticides observed in freshwater systems.


Subject(s)
Environmental Monitoring , Insecticides/analysis , Wetlands , Acer/drug effects , Animals , Anura , Ecology , Ecosystem , Fresh Water , Larva/drug effects , Malathion/toxicity , Phytoplankton/drug effects , Plant Leaves/chemistry , Plants/drug effects , Quercus/drug effects , Zooplankton/drug effects
2.
Am J Transplant ; 16(9): 2639-45, 2016 09.
Article in English | MEDLINE | ID: mdl-27013023

ABSTRACT

The allocation system of donor organs for transplantation may affect their scarcity. In 2008, Israel's Parliament passed the Organ Transplantation Law, which grants priority on waiting lists for transplants to candidates who are first-degree relatives of deceased organ donors or who previously registered as organ donors themselves. Several public campaigns have advertised the existence of the law since November 2010. We evaluated the effect of the law using all deceased donation requests made in Israel during the period 1998-2015. We use logistic regression to compare the authorization rates of the donors' next of kin in the periods before (1998-2010) and after (2011-2015) the public was made aware of the law. The authorization rate for donation in the period after awareness was substantially higher (55.1% vs. 45.0%, odds ratio [OR] 1.43, p = 0.0003) and reached an all-time high rate of 60.2% in 2015. This increase was mainly due to an increase in the authorization rate of next of kin of unregistered donors (51.1% vs. 42.2%). We also found that the likelihood of next-of-kin authorization for donation was approximately twice as high when the deceased relative was a registered donor rather than unregistered (89.4% vs. 44.6%, OR 14.27, p < 0.0001). We concluded that the priority law is associated with an increased authorization rate for organ donation.


Subject(s)
Brain Death/legislation & jurisprudence , Health Plan Implementation , Tissue Donors/supply & distribution , Tissue and Organ Procurement/legislation & jurisprudence , Family , Humans , Time Factors , Tissue and Organ Procurement/statistics & numerical data , Tissue and Organ Procurement/trends , Waiting Lists
3.
Am J Transplant ; 13(3): 780-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23279738

ABSTRACT

Israel's organ donation rate has always been among the lowest in Western countries. In 2008 two new laws relevant to organ transplantation were introduced. The Brain-Respiratory Death Law defines the precise circumstances and mechanisms to determine brain death. The Organ Transplantation Law bans reimbursing transplant tourism involving organ trade, grants prioritization in organ allocation to candidates who are registered donors and removes disincentives for living donation by providing modest insurance reimbursement and social supportive services. The preliminary impact of the gradual introduction and implementation of these laws has been witnessed in 2011. Compared to previous years, in 2011 there was a significant increase in the number of deceased organ donors directly related to an increase in organ donation rate (from 7.8 to 11.4 donors per million population), in parallel to a significant increase in the number of new registered donors. In addition the number of kidney transplantations from living donors significantly increased in parallel to a significant decrease in the number of kidney transplantations performed abroad (from 155 in 2006 to 35 in 2011). The new laws have significantly increased both deceased and living organ donation while sharply decreasing transplant tourism.


Subject(s)
Brain Death/legislation & jurisprudence , Health Plan Implementation , Tissue Donors/supply & distribution , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/trends , Humans , Medical Tourism , Tissue and Organ Procurement/statistics & numerical data
7.
Int J Oncol ; 17(6): 1231-5, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11078810

ABSTRACT

p21WAF1/CIP1 protein is a cyclin-dependent kinase inhibitor, able to prevent the CDK2/cyclin E induced retinoblastoma protein (pRB) phosphorylation, thus inhibiting cell cycle progression at G1 phase. p21WAF1/CIP1 protein levels were examined in a series of 102 ovarian tissue samples including normal ovary, primary ovarian tumors, omental metastasis, recurrent disease and residual tumor after chemotherapy exposure, by Western blot analysis. The association of p21WAF1/CIP1 status with clinicopathological parameters and clinical outcome was also investigated. p21WAF1/CIP1 protein was detectable in 76 out of 102 (74%) ovarian tissue samples. We observed a significant trend of p21 levels to gradually increase from normal ovarian tissues (median 0 a.u.) through primary ovarian cancers (median 0.19 a.u.), omental metastases (median 0.33 a.u.) and recurrence of disease (median 0.44 a.u.) (p=0.015). In the group of stage III-IV ovarian cancer patients, p21-positive cases showed a more favourable prognosis with respect to p21-negative cases: the 3-year time to progression (TTP) rate was 58% for p21-positive compared with 33% of p21-negative cases (p=0.036). In conclusion, p21WAF1/CIP1 expression levels seem to be correlated with tumor status at the time of diagnosis and can predict TTP in a selected group of patients.


Subject(s)
Cyclins/biosynthesis , Cystadenocarcinoma, Serous/metabolism , Gene Expression Regulation, Neoplastic , Neoplasm Proteins/biosynthesis , Ovarian Neoplasms/metabolism , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Endometrioid/drug therapy , Carcinoma, Endometrioid/genetics , Carcinoma, Endometrioid/metabolism , Carcinoma, Endometrioid/pathology , Carcinoma, Endometrioid/secondary , Carcinoma, Endometrioid/surgery , Cell Cycle , Cisplatin/administration & dosage , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , Cystadenocarcinoma, Mucinous/drug therapy , Cystadenocarcinoma, Mucinous/genetics , Cystadenocarcinoma, Mucinous/metabolism , Cystadenocarcinoma, Mucinous/pathology , Cystadenocarcinoma, Mucinous/secondary , Cystadenocarcinoma, Mucinous/surgery , Cystadenocarcinoma, Serous/drug therapy , Cystadenocarcinoma, Serous/genetics , Cystadenocarcinoma, Serous/pathology , Cystadenocarcinoma, Serous/secondary , Cystadenocarcinoma, Serous/surgery , Disease Progression , Female , Genes, p53 , Humans , Life Tables , Middle Aged , Neoplasm Proteins/genetics , Neoplasm Recurrence, Local , Neoplasm Staging , Neoplasm, Residual , Omentum , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Ovary/metabolism , Peritoneal Neoplasms/metabolism , Peritoneal Neoplasms/secondary , Survival Analysis , Treatment Outcome
8.
Oncol Res ; 12(9-10): 429-40, 2000.
Article in English | MEDLINE | ID: mdl-11697821

ABSTRACT

Evidences have been reported that phenylacetic (PA) and phenylbutyric (PB) fatty aromatic acids can exert tumor growth inhibition in vitro and in vivo. Moreover, clinical trials also showed some activity for these drugs to modulate the expression of genes implicated in tumor growth, metastasis, immunogenicity, and to potentiate the efficacy of cytotoxic agents. The aim of the study was to examine the effects of PA and PB on the growth as well as sensitization to cisplatin and radiation in human cervical cancer cells. The effects of PA and PB on the proliferative activity and apoptosis induction in cervical tumor tissue was investigated. Both PA and PB exhibited a time- and dose-dependent antiproliferative activity in SW756 and ME180 cell lines: after 72-h treatment, the IC50 (concentration able to inhibit 50% of cell growth) of PB was 1.9 +/- 0.2 mM and 1.5 +/- 0.2 mM in SW756 and ME180 cells, respectively, while the IC50 of PA was 13.0 +/- 1.7 mM and 10.0 +/- 1.2 mM in SW756 and ME180 cells, respectively. In tumor tissue biopsies obtained from patients affected by squamous cervical cancer, both drugs resulted in a marked reduction of the percentage of bromodeoxyuridine-labeled cells compared with untreated samples [19.0 +/- 1.63% in untreated tissues with respect to 1.30 +/- 0.54% and 4.20 +/- 2.50% of stained cells after treatment with PA (30 mM) (P < 0.0001) and PB (5 mM) (P < 0.0001), respectively]. Moreover, analysis of the staining with M30 monoclonal antibody revealed that PA (30 mM) and PB (5 mM) were able to produce a marked increase in the number of stained apoptotic nuclei with respect to untreated samples. Finally, PB and PA were shown to enhance the sensitivity of SW756 to radiation and to exert an additive effect when combined with cisplatin. A significant reduction of the processed form of p21ras and rhoB proteins in the membrane fraction of cells exposed to PA and PB was observed. When farnesol, which is able to circumvent the enzymatic step inhibited by PA and PB, was added to the medium only a partial reversal of the growth inhibition and potentiation of sensitivity to radiation induced by PA and PB were found. In conclusion, the growth inhibitory properties of fatty aromatic acids suggest that these molecules could represent the prototype of a new class of compounds with some therapeutic potential in cervical cancer.


Subject(s)
Fatty Acids/pharmacology , Radiation-Sensitizing Agents/therapeutic use , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/radiotherapy , Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents/therapeutic use , Apoptosis , Bromodeoxyuridine/pharmacology , Cell Cycle , Cell Division , Cisplatin/therapeutic use , Combined Modality Therapy , DNA Fragmentation , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Female , Humans , Inhibitory Concentration 50 , Keratins/metabolism , Phenylacetates/pharmacology , Phenylbutyrates/pharmacology , Proto-Oncogene Proteins p21(ras)/metabolism , Time Factors , Tumor Cells, Cultured , rhoB GTP-Binding Protein/metabolism
9.
Implant Dent ; 7(3): 177-84, 1998.
Article in English | MEDLINE | ID: mdl-9823105

ABSTRACT

Patients who are to receive implant therapy and are about to undergo radiation treatment require a means to eliminate, or reduce, the amount of radiation received by the implants and their osseous housing. This requirement is even more important if the implants were recently inserted and osseointegration (Sigma) has not yet been achieved. Lead shielding of the implant sites protects the fixtures and the surrounding bone so that osseointegration can be achieved and maintained.


Subject(s)
Cranial Irradiation , Dental Care for Chronically Ill , Dental Implantation, Endosseous/methods , Osteoradionecrosis/prevention & control , Radiation Protection , Adult , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/rehabilitation , Carcinoma, Squamous Cell/surgery , Cranial Irradiation/adverse effects , Humans , Male , Mouth, Edentulous/rehabilitation , Osteoradionecrosis/etiology , Patient Care Planning , Tonsillar Neoplasms/radiotherapy , Tonsillar Neoplasms/rehabilitation , Tonsillar Neoplasms/surgery
10.
Carcinogenesis ; 18(1): 15-21, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9054584

ABSTRACT

Gap junction intercellular communication (GJIC) has been measured in cell lines that represent different stages of chemically induced mouse skin carcinogenesis. No significant difference in GJIC, as measured by dye spread, was found in cultures of normal keratinocyte, papilloma or squamous carcinoma cell lines. There was no correlation, in this system, between the presence of a mutant Ha-ras gene and down-regulation of communication. There was, however, a marked decrease in GJIC (80-90%) on progression from squamous to spindle carcinoma cells. Measurement of GJIC in somatic cell hybrids shows that the genetic defect responsible for this down-regulation is recessive and is common to two independently isolated spindle cell lines. No abnormalities were found in the spindle cells in expression of connexin 43, a cell component involved in gap junction formation and permeability. However, expression of E-cadherin, a cell-cell adhesion molecule implicated in the process of gap junction formation, was missing in the spindle carcinoma cells. Introduction of an E-cadherin cDNA into the spindle cells partially restored junctional communication without causing any noticeable alterations in cell morphology. During the study a non-tumourigenic keratinocyte line, a sub-clone of a normal keratinocyte line, was also found to have a low level of GJIC. However, the defect in this line was shown, by genetic complementation in somatic cell hybrids, to be different from that in the spindle carcinoma cell lines. Consistent with these data, analysis by immunofluorescence shows an abnormal distribution of connexin 43 in these cells.


Subject(s)
Cadherins/metabolism , Carcinoma, Squamous Cell/physiopathology , Carcinoma/physiopathology , Cell Communication/physiology , Gap Junctions/physiology , Neoplasm Proteins/metabolism , Papilloma/physiopathology , Skin Neoplasms/physiopathology , Animals , Cadherins/genetics , Carcinoma/chemically induced , Carcinoma/genetics , Carcinoma/metabolism , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Cell Communication/genetics , Connexin 43/genetics , Connexin 43/metabolism , Gap Junctions/genetics , Keratinocytes/metabolism , Keratinocytes/physiology , Mice , Neoplasm Proteins/genetics , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/genetics , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/physiopathology , Papilloma/chemically induced , Papilloma/genetics , Papilloma/metabolism , Skin Neoplasms/chemically induced , Skin Neoplasms/genetics , Skin Neoplasms/metabolism
11.
J Infect Dis ; 174(1): 214-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8655998

ABSTRACT

This study investigates the effects of cysteamine alone and in association with zidovudine or didanosine on the replication of human immunodeficiency virus type 1 (HIV-1). More than 90% viral inhibition was obtained by 200 microM cysteamine in lymphocytes and 100 microM cysteamine in macrophages against 4 primary isolates and 2 laboratory strains of HIV-1. Polymerase chain reaction analysis demonstrated that cysteamine interferes with early steps of HIV-1 replication, before proviral DNA formation. The use of cysteamine in conjunction with zidovudine or didanosine brought about an additive antiviral effect without concomitant increases in toxicity. The concentrations of cysteamine that are effective against HIV-1 in vitro have been well tolerated over long periods by patients under treatment for cystinosis, an inherited disorder. These observations suggest that cysteamine alone or in combination with zidovudine or didanosine could be a new potential treatment of HIV-1 infection.


Subject(s)
Antiviral Agents/pharmacology , Cysteamine/pharmacology , HIV-1/drug effects , Cell Death/drug effects , Cells, Cultured/drug effects , Cells, Cultured/virology , DNA, Viral/drug effects , Didanosine/pharmacology , Drug Therapy, Combination , HIV Core Protein p24/biosynthesis , HIV Core Protein p24/drug effects , Humans , Macrophages/drug effects , Macrophages/virology , Monocytes/drug effects , Monocytes/virology , Polymerase Chain Reaction , Zidovudine/pharmacology
12.
J Oral Implantol ; 22(3-4): 247-57, 1996.
Article in English | MEDLINE | ID: mdl-9524503

ABSTRACT

Subperiosteal implant is the treatment of choice for the fully or partially edentulous atrophic mandible if grafting procedures are not contemplated to give the jaw sufficient available bone for endosseous implants. The main disadvantage of the standard technique for the construction of this implant is that it requires two surgical procedures. However, it is an accepted and proven technique with a long-term survival rate. This paper discusses the use of the CT scan subperiosteal implant, which provides a result similar to that of the standard subperiosteal implant, but requires only one surgical procedure. The accuracy of fit of the CT scan subperiosteal implant is similar to that of the implant fabricated by means of a standard two-surgical-impression technique. New updated CT scan machines use faster helical scanners and offer a great improvement over previous CT scan machines. The new CT scan machines reduce the chance of patient movement, produce a more accurate CT scan, and enable a more accurate model of the mandible or maxilla to be developed. This paper discusses the production of a well-fitting CT scan subperiosteal implant by a trained, knowledgeable, and cooperative team of dentist, CT scan technician, and radiologist, all of whom understand the technical means to achieve their goal.


Subject(s)
Alveolar Bone Loss/rehabilitation , Computer-Aided Design , Dental Implantation, Subperiosteal , Dental Implants , Dental Prosthesis Design/methods , Jaw, Edentulous/diagnostic imaging , Jaw, Edentulous/rehabilitation , Tomography, X-Ray Computed/methods , Humans , Patient Care Planning , Patient Care Team , Prosthesis Fitting , Tomography, X-Ray Computed/instrumentation
13.
Invasion Metastasis ; 14(1-6): 7-16, 1994.
Article in English | MEDLINE | ID: mdl-7657534

ABSTRACT

The ultimate stage of carcinogenesis in both human and mouse epithelial cells is the ability to invade surrounding tissues and metastasize to distant sites. In mouse skin tumours, the development of the invasive, spindle cell phenotype is associated with an imbalance of alleles on mouse chromosome 7, including the H-ras gene. In previous work, we have described clonally related squamous and spindle cell lines from the same primary tumour which differed substantially in morphology and behaviour, but showed the same series of mutations in H-ras and p53 genes. One of the events which takes place during this transition is disruption of cell-cell contacts, possibly due to the induced expression of metalloproteinases such as stromelysin-1 and disappearance of the cell adhesion molecule E-cadherin. Parallel studies using somatic cell hybrids have shown that the spindle cell phenotype is recessive in hybrids between squamous and spindle cells. We propose that an important epidermal differentiation-controlling gene is lost during the spindle cell transition.


Subject(s)
Skin Neoplasms/pathology , Skin Neoplasms/secondary , Animals , Carcinoma/genetics , Carcinoma/pathology , Carcinoma/secondary , Disease Progression , Mice , Neoplasm Invasiveness , Phenotype , Skin Neoplasms/genetics , Tumor Cells, Cultured
14.
J Cell Biol ; 122(5): 1103-17, 1993 Sep.
Article in English | MEDLINE | ID: mdl-7689080

ABSTRACT

Squamous carcinomas of both human and rodent origin can undergo a transition to a more invasive, metastatic phenotype involving reorganization of the cytoskeleton, loss of cell adhesion molecules such as E-cadherin and acquisition of a fibroblastoid or spindle cell morphology. We have developed a series of cell lines from mouse skin tumors which represent different stages of carcinogenesis, including benign papillomas, and clonally related squamous and spindle carcinomas derived from the same primary tumor. Some spindle cells continue to express keratins, but with a poorly organized keratin filament network, whereas in others no keratin expression is detectable. All of the spindle cells lack expression of the cell adhesion molecule E-cadherin and the desmosomal component desmoplakin. Loss of these cell surface proteins therefore appears to precede the destabilization of the keratin network. At the genetic level, it is not known whether such changes involve activation of dominantly acting oncogenes or loss of a suppressor function which controls epithelial differentiation. To examine this question, we have carried out a series of fusion experiments between a highly malignant mouse skin spindle cell carcinoma and cell lines derived from premalignant or malignant mouse skin tumors, including both squamous and spindle carcinoma variants. The results show that the spindle cell phenotype as determined by cell morphology and lack of expression of keratin, E-cadherin, and desmoplakin proteins, is recessive in all hybrids with squamous cells. The hybrids expressed all of these differentiation markers, and showed suppression of tumorigenicity to a variable level dependent upon the tumorigenic properties of the less malignant fusion partner. Our results suggest that acquisition of the spindle cell phenotype involves functional loss of a gene(s) which controls epithelial differentiation.


Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinoma/pathology , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Genes, Recessive/genetics , Skin Neoplasms/pathology , Animals , Antigens, Differentiation/analysis , Antigens, Differentiation/genetics , Cadherins/analysis , Cadherins/genetics , Carcinoma/chemistry , Carcinoma/ultrastructure , Carcinoma, Squamous Cell/chemistry , Carcinoma, Squamous Cell/ultrastructure , Cytoskeletal Proteins/analysis , Cytoskeletal Proteins/genetics , Cytoskeleton/chemistry , Cytoskeleton/ultrastructure , Desmoplakins , Epidermis/chemistry , Epidermis/pathology , Epidermis/ultrastructure , Fluorescent Antibody Technique , Gene Expression Regulation/genetics , Genes, Suppressor/genetics , Genes, Suppressor/physiology , Hybrid Cells/chemistry , Immunohistochemistry , Keratins/analysis , Keratins/genetics , Mice , Phenotype , Skin Neoplasms/chemistry , Skin Neoplasms/ultrastructure , Tumor Cells, Cultured
16.
J Oral Implantol ; 18(1): 38-44, 1992.
Article in English | MEDLINE | ID: mdl-1289540

ABSTRACT

A young Ecuadorian girl underwent a total mandibulectomy due to infected fibrous dysplasia. In the subsequent 16 years, she was unable to speak intelligibly or masticate, surviving on liquids alone. After referral to the United States, the patient underwent six major surgical procedures that reconstructed her mandible from cranial and microvascular iliac crest grafts. The reconstruction improved her appearance and prepared her for insertion of dental implants and the eventual construction of a prosthetic device. These resulted in both functional and esthetic benefits.


Subject(s)
Bone Transplantation/methods , Mandible/surgery , Oral Surgical Procedures, Preprosthetic/methods , Adult , Female , Humans , Ilium/blood supply , Microcirculation , Microsurgery/methods , Reoperation
17.
J Oral Implantol ; 18(1): 45-53, 1992.
Article in English | MEDLINE | ID: mdl-1289541

ABSTRACT

A 28-year-old Hispanic girl underwent a complete mandibular reconstruction many years following full mandibulectomy for fibrous dysplasia. Because of infectious complications, both free cranial and microvascular iliac crest grafts were used. The patient had osseointegrated implants placed directly into the grafted mandible. Osseointegrated implants were also placed into a segment of free iliac crest bone, in vitro, and then grafted laterally onto the reconstructed mandible. Prosthetic reconstruction was then carried out to restore the patient to normal function, health, comfort, and esthetics.


Subject(s)
Bone Transplantation/methods , Dental Implantation, Endosseous/methods , Denture, Overlay , Mandible/surgery , Oral Surgical Procedures, Preprosthetic/methods , Adult , Female , Humans , Osseointegration , Patient Care Planning
18.
Br Med Bull ; 47(1): 64-75, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1863849

ABSTRACT

Cancer can be considered a genetic disorder of somatic cells. Strong evidence comes from several areas: (1) chromosomal analysis reveals cancer cells have abnormal karyotypes; (2) some inherited syndromes are associated with an increased risk of cancer and for others, cancer itself occurs as an inherited trait; (3) cells can become malignant by a variety of agents that damage DNA, and (4) some types of viruses can induce tumours. One common thread has been the normal cellular sequences transduced by viruses and mutated to become oncogenic (oncogenes) are the same sequences to become activated by nonviral mechanisms. These oncogenes appear involved in cell proliferation and/or differentiation and their products apparently function in the signal transduction pathway from the cell exterior to the nucleus. In addition, evidence from familial studies indicate mutations associated with gene inactivation or loss of function are also important in the aetiology of tumour formation. These genes, termed tumour suppressor genes, seem to be involved in the negative control of cellular proliferation. Cancer is a multistep process and it is now becoming clear that the different stages involve genetic alterations in both oncogenes and tumour suppressor genes.


Subject(s)
Genes, Tumor Suppressor , Neoplasms/genetics , Oncogenes , Humans , Signal Transduction
19.
Princess Takamatsu Symp ; 22: 97-108, 1991.
Article in English | MEDLINE | ID: mdl-1844254

ABSTRACT

Studies of multistage carcinogenesis in mouse skin have provided many of the early concepts of tumour initiation, promotion and progression. Genetic approaches have led to the identification of a number of mutational alterations in proto-oncogenes and tumour suppressor genes which take place at specific stages of carcinogenesis in this particular system. Initiation involves, at least in a proportion of tumours, mutational activation of the cellular H-ras proto-oncogene. Trisomy of chromosome 7, which develops during the premalignant clonal expansion phase, possibly as a consequence of tumour promoter treatment, is followed by further alterations on chromosome 7 which lead to a relative increase in the expression of mutant ras alleles. The p53 tumour suppressor gene undergoes mutational alteration and loss of heterozygosity in a proportion of squamous carcinomas but this particular gene does not appear to be involved in the further transition of squamous carcinomas to highly undifferentiated spindle cell tumours. The latter transition appears to be a recessive event which can be complemented by fusion with cells at earlier stages of malignancy. Mouse skin carcinogenesis therefore continues to provide invaluable information on the nature of the genetic and biological transitions which occur during the step-wise progression of normal cells to malignancy.


Subject(s)
Genes, Tumor Suppressor , Skin Neoplasms/genetics , Animals , Carcinoma/chemically induced , Carcinoma/genetics , Carcinoma/pathology , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic , Genes, ras , Humans , Mice , Mutation , Proto-Oncogene Mas , Skin Neoplasms/chemically induced , Skin Neoplasms/pathology , Transforming Growth Factor beta/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...